EichorEICHOR
Location: Kogarah Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Kogarah

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Tissue Repair Gel in Venous Leg Ulcers in AU/US
Phase 3 · Clinical Research Site 84 · TR Therapeutics · NCT06707103A Platform Trial for Gram Negative Bloodstream Infections
NA · St George Hospital · Sunnybrook Health Sciences Centre · NCT06537609ROADMAP Clinical Trial
Phase 4 · St George · University of Newcastle, Australia · NCT06771050A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Southern Neurology · Bristol-Myers Squibb · NCT06976216INOPASE - Performance and Safety Study of a Personalised SNM System
NA · St George Private Hospital · INOPASE Pty Ltd · NCT07193407A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · St George Hospital · Biogen · NCT06962800A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · St George Hospital · Boehringer Ingelheim · NCT07220083Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · St George Hospital · Leiden University Medical Center · NCT05393791Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Phase 2 · Research Site · AstraZeneca · NCT06526793Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · St George Hospital · Corvus Pharmaceuticals, Inc. · NCT06561048A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Southern Neurology · Hoffmann-La Roche · NCT07174310A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relap
Phase 1/Phase 2 · St George Hospital · BeOne Medicines · NCT06634589The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · St George Hospital · The George Institute · NCT06058585Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · St. George Private Hospital Clinical Trials Unit · Revolution Medicines, Inc. · NCT06881784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · St George Hospital - Kogarah /ID# 277168 · AbbVie · NCT07155187Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · St George Hospital · BeOne Medicines · NCT06943872Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · St George Hospital · The University of Queensland · NCT03573089Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/Phase 2 · St George Private Hospital · Filamon LTD · NCT06926075A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Gener
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06744920PRECISION-TBI - An Observational Study of Patients With Moderate to Severe Traumatic Brain Injury
Phase N/A · St George Hospital · Australian and New Zealand Intensive Care Research Centre · NCT05855252Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · St George Private Hospital · Vertex Pharmaceuticals Incorporated · NCT07204275ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Phase 3 · St George Hospital · Australian and New Zealand Intensive Care Research Centre · NCT04588311Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06858319A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · St George Hospital · Janssen Research & Development, LLC · NCT06852222Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Phase 3 · St George Hospital · The George Institute · NCT05752279A Study of LY3439539 in Participants With Alzheimer's Disease
Phase 1 · Southern Neurology · Eli Lilly and Company · NCT07598370An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies
Phase 1 · St George Hospital · BeOne Medicines · NCT07619287A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative He
Phase 3 · St George Hospital · AVEO Pharmaceuticals, Inc. · NCT06064877
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.